Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standardof care (SoC) therapy in subjects with inoperable, advanced, somatostatin receptor expressing (SSTR+),well-differentiated gastro-enteropancreatic

Greeno, Edward W (PI)

Medicine - Hematology, Oncology, Transplant

Project: Research project

Description

Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects with inoperable, advanced, somatostatin receptor expressing (SSTR+), well-differentiated gastro-enteropancreatic

Status	Active
Effective start/end date	1/19/24 → 1/31/34

Funding

RAYZEBIO, INC.

Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standardof care (SoC) therapy in subjects with inoperable, advanced, somatostatin receptor expressing (SSTR+),well-differentiated gastro-enteropancreatic

Project Details

Description

Funding

Fingerprint